VidhiAagaz
International Journal ofLaw Management & Humanities
ISSN 2581-5369 · Open access
International Journal ofLaw Management & Humanities
Open accessArticlesVol. 8 No. I (2025)pp. 1783–1793

Roles and Responsibilities of Art Clinics in India: A Comparative Analysis

VP
Varalika S. ParasharAssistant Professor at Faculty of Law, Oriental University, Indore, India
648views274downloads
Published 1 March 2025 · pp. 1783–1793 · Vol. 8 No. I (2025)
Abstract

Surrogacy, especially within the framework of ART (Assisted Reproductive Technology) clinics, is a multifaceted process that involves the collaborative efforts of various stakeholders, including surrogates, intended parents, medical professionals, and legal experts. This paper explores the roles and responsibilities of each party involved in the surrogacy process, with a particular focus on ART clinics. Surrogates are entrusted with carrying the child, adhering to medical guidelines, and ensuring their own health during the pregnancy. Intended parents provide necessary emotional and financial support while ensuring compliance with legal and ethical standards. ART clinics play a central role in providing medical care, such as IVF procedures, and ensuring the safety of both the surrogate and the child. Legal experts ensure that the surrogacy arrangement is formally regulated to protect the rights of all parties. By examining the responsibilities within this collaborative framework, this paper underscores the importance of ethical practices, clear communication, and a well-defined legal structure to ensure a successful surrogacy experience.

Keywords
SurrogacyART ClinicsAssisted Reproductive TechnologyIVFSurrogate MotherIntended ParentsEthical PracticesPregnancy ManagementReproductive RightsSurrogacy AgreementsStakeholder Responsibilities
Contents
Full text

INTRODUCTION

Assisted Reproductive Technology (ART) has been a transformative solution for individuals and couples who wish to have children but face biological or medical challenges. Many of these individuals opt for ART rather than adoption. One widely used ART technique is surrogacy, where a woman carries and gives birth to a child for another individual or couple. While some engage in surrogacy as an act of goodwill, others do so commercially, leading to what is termed "surrogacy consumerism." High costs associated with ART procedures in wealthier nations have driven many intended parents to seek surrogates in lower-income countries like Nepal, Thailand, and India, where surrogacy has historically been more affordable. India, in particular, emerged as a global hub for commercial surrogacy after legalizing the practice in 2002, owing to its well-established medical infrastructure and relatively lenient legal framework. However, concerns over the exploitation of impoverished women and ethical dilemmas surrounding commercial surrogacy prompted the Indian government to ban the practice through the Surrogacy (Regulation) Act, 2021, which came into effect in January 2022. This complex landscape of surrogacy has been reflected in Indian popular culture, with Bollywood films such as Chori Chori Chupke Chupke, Filhaal, and Mimi portraying various facets of surrogacy. These films highlight the evolving social, legal, and cultural attitudes toward ART and surrogacy in India, from its initial perception as an altruistic act to its commodification by the global elite.2

Alongside surrogacy, in vitro fertilization (IVF)—a key ART procedure—has drawn comparisons to age-old narratives in Indian mythology. A study published in the Indian Journal of Endocrinology and Metabolism examines the Mahabharata through the lens of reproductive endocrinology, particularly the story of Gandhari, who gave birth to a lump of mass that was divided and incubated to produce a hundred sons. This story bears a striking resemblance to the modern IVF process, especially in cases of multiple pregnancies. ART has witnessed significant advancements over the years, beginning with the birth of the world's first test tube baby in 1978. Recognizing the need for regulation, the Indian Council of Medical Research (ICMR) introduced the National Guidelines for Accreditation, Supervision & Regulation of ART Clinics in India in 2005. After more than a decade, the Assisted Reproductive Technology (Regulation) Act, 2021 was enacted on December 18, 2021, and came into force on January 25, 2022. The Act was designed to regulate ART clinics and banks, ensuring safe, ethical, and legally compliant practices. Further, the Assisted Reproductive Technology (Regulation) Rules, 2022, introduced on June 7, 2022, laid down detailed procedural guidelines. The legal and ethical debates surrounding ART and surrogacy continue, with ongoing discussions about accessibility, exploitation, and reproductive rights. The impact of these regulations on ART services in India will shape the future of reproductive healthcare in the country.

LAWS AND GUIDELINES RELATED TO ART CLINICS

As per Section 2(c) of the Act, an ART clinic is defined as: "Any premises equipped with requisite facilities and medical practitioners registered with the National Medical Commission for carrying out ART procedures." Under Rule 3(1), ART clinics are classified into two levels based on the services they provide. The Act stipulates that the executive head of an ART clinic is liable for any offences committed under its provisions, unless they can demonstrate lack of knowledge or due diligence in preventing such violations. The law underscores the necessity for ART clinics to establish Standard Operating Procedures (SOPs) to ensure compliance. The impact of the Act was evident in the case of Rakhi Bose v. Union of India (2022) before the Kerala High Court. A married couple, who had undergone oocyte retrieval in 2014 and preserved their embryos, sought permission to transfer the frozen embryos to another hospital for continued treatment. However, the newly enacted Act imposed restrictions on embryo transfers, leading the hospital to deny the request. The couple approached the Court, arguing that the law should not create undue hurdles for those seeking ART services. The Court ruled that the primary objective of the Act was to regulate and supervise ART clinics while ensuring ethical practices, not to obstruct access to ART. Consequently, the Court permitted the embryo transfer. The Act mandates the registration of ART clinics, requiring them to apply within 60 days of the establishment of the National Registry. Initially, the registration certificate is valid for five years, with provisions for renewal for an additional five years.3

A recent case in Tamil Nadu, where a 16-year-old girl was allegedly coerced into selling her oocytes using a forged Aadhaar card, highlights the pressing need for strict regulations. With the growing number of ART clinics and the rising demand for ART services, the Legislature has sought to address ethical concerns through this Act. However, its constitutional validity is currently being challenged in the Delhi High Court. Petitioners argue that the Act is discriminatory, as it primarily covers commissioning couples and women while excluding single men, LGBTQ individuals, live-in couples, and those with secondary infertility. The Assisted Reproductive Technology (Regulation) Act, 2021, along with the Surrogacy (Regulation) Act, 2021, continues to face legal scrutiny. The coming years will determine whether these laws strike the right balance between regulation, accessibility, and individual reproductive rights.4

MAJOR DUTIES OF ART CLINICS

Chapter IV of the Act and the Rules outline the responsibilities of ART clinics, including5:

•  Written Consent and Use Restrictions: ART clinics must obtain written informed consent from individuals undergoing ART procedures. Cryopreservation of embryos or gametes requires explicit written instructions from all concerned parties. Clinics are prohibited from using reproductive material contrary to the provisions of the Act.

•  Maintaining Accurate Records: Clinics must keep detailed records for at least ten years. After this period, records must be transferred to the National Registry. Additionally, records must be accessible for inspection by the National/State Board and the National Registry. If a clinic is involved in any legal proceedings, its records must be preserved until the case is resolved.

•  Other Responsibilities and Prohibitions: The Act imposes strict guidelines on the use of human gametes and embryos, particularly regarding Preimplantation Genetic Diagnosis (PGD). Notably, it prohibits clinics from offering procedures that allow parents to predetermine the sex of a child. The Rules further specify staffing requirements, necessary equipment, and mechanisms for grievance redressal.

COMPARATIVE ANALYSIS OF THE ROLE OF ART CLINICS IN INDIA AND OTHER COUNTRIES WITH SPECIAL REFERENCE TO USA

1. Assisted Reproductive Technology (ART) clinics play a crucial role in addressing infertility issues worldwide.

The regulation, ethical considerations, and societal attitudes toward ART and surrogacy vary significantly across different countries. India, particularly Anand, has been a hub for ART and surrogacy, attracting international couples due to lower costs and relatively lax regulations. In contrast, countries like the United States, Canada, Germany, Nepal, and Thailand have adopted stricter policies concerning ART and surrogacy. This paper presents a comparative analysis of the role of ART clinics in India and other countries, focusing on ethical concerns, regulations, and economic factors.6

2. India has been a prominent destination for ART procedures, particularly surrogacy.

The clinic in Anand, led by Dr. Nayna Patel, reported a 44% success rate in 2006, attracting couples from the Global North, including Germany, Canada, and the U.S. The affordability of ART procedures, compared to developed nations, contributed significantly to India's prominence in this field. However, concerns about commercial surrogacy’s ethical implications led to the Indian government banning commercial surrogacy in 2019. Before the ban, financial exploitation of surrogates, lack of comprehensive legal protection, and inadequate healthcare provisions for surrogate mothers were common issues.7

3. ART Clinics in the United States and Canada in contrast to India, ART clinics in the United States operate under stringent legal frameworks

The U.S. has a state-based regulatory approach, with some states permitting commercial surrogacy while others prohibit it. The cost of ART procedures in the U.S. is significantly higher, with surrogates receiving substantial compensation compared to India. The ethical framework ensures surrogate mothers have access to legal, medical, and psychological support, reducing potential exploitation. Canada, on the other hand, follows an altruistic surrogacy model, where only expenses are reimbursed, prohibiting financial incentives for surrogates. This regulation ensures that surrogacy remains an act of altruism rather than a commercial enterprise.8

4. ART Clinics in Germany Germany has some of the strictest ART regulations, including a complete ban on commercial surrogacy

The Embryo Protection Act, 1990 criminalizes surrogacy and restricts certain ART procedures, reflecting the country’s emphasis on ethical concerns over commercial interests. Unlike India, where surrogacy was once a booming industry, Germany prioritizes stringent oversight to prevent potential exploitation of women and children born through ART.9

5. ART Clinics in Nepal and Thailand Similar to India, Nepal and Thailand initially had thriving commercial surrogacy industries, catering to international couples.

However, ethical concerns and cases of exploitation led to the prohibition of commercial surrogacy in both countries by 2015. In Nepal, the lack of regulatory oversight resulted in cases where surrogate mothers were denied adequate postnatal care. Thailand, following a high-profile case involving a surrogate mother’s refusal to relinquish a child, enacted strict laws prohibiting foreign couples from engaging in surrogacy.10

The primary ethical concerns surrounding ART and surrogacy involve the potential exploitation of financially disadvantaged women, the commodification of childbirth, and the well-being of surrogate mothers and children. In India, surrogacy was driven by economic necessity, which often led to suboptimal healthcare and legal protection for surrogates. By contrast, countries like Canada and Germany focus on ethical and legal safeguards, preventing commercialization. Economically, India’s lower costs made it an attractive destination for international couples, but the lack of stringent oversight led to reported cases of unethical practices. ART clinics play a vital role in addressing infertility but require robust regulatory frameworks to prevent exploitation. India’s surrogacy industry flourished due to economic advantages but faced severe ethical criticism, leading to the 2019 ban on commercial surrogacy. Countries like the U.S. and Canada maintain stricter regulations, ensuring better protection for all parties involved, while Germany prohibits commercial surrogacy entirely. The experiences of Nepal and Thailand further illustrate the need for comprehensive legal frameworks to balance reproductive rights and ethical considerations. Moving forward, India can draw lessons from these countries to develop a more ethical and regulated ART framework that safeguards surrogate mothers' rights while supporting intended parents.

COMPARATIVE CHALLENGES: U.S. VS. INDIAN PERSPECTIVES

1. Balancing Reproductive Autonomy and State Oversight

In US, the debate centers on a robust notion of procreative liberty—rooted in constitutional privacy rights (e.g., Griswold v. Connecticut)—which makes any government restriction on ART subject to rigorous judicial scrutiny. In contrast, India has adopted a framework that emphasizes ethical oversight and state regulation through laws such as the ART (Regulation) Act, 2021 and the Surrogacy (Regulation) Act, 2021. This framework imposes strict eligibility criteria and licensing requirements, leading to concerns over state overreach that may restrict individual autonomy under Article 21.11

2. Uniformity versus Over-Regulation

In USA, the absence of a centralized federal law results in inconsistencies among state policies. This patchwork regulation can lead to varying standards for ethical practice, cost, and access. The centralized regulatory model aims to prevent unethical practices (e.g., commercial surrogacy) but has been critiqued for being overly restrictive, especially regarding access for unmarried individuals, LGBTQ+ couples, and foreign nationals.12

3. Ethical and Social Concerns

Courts generally favor individual choice, yet ethical dilemmas persist regarding issues like embryo selection, genetic modification, and third-party reproductive assistance. In India, legal measures prioritize broader societal values and potential risks of exploitation—particularly in surrogacy—while also grappling with cultural norms and ethical debates over emerging reproductive technologies.13

4. Judicial Interpretation and Evolving Rights

In USA, evolving case law (e.g., Roe v. Wade, Planned Parenthood v. Casey) has shaped a landscape in which reproductive rights are defended, but ART-specific rights have not been fully delineated. Although Indian jurisprudence under Article 21 recognizes the right to personal liberty and life, explicit legal recognition of a broad ART right remains ambiguous, leaving the door open for future legal challenges and reinterpretations.14

5. Access and Affordability

In USA, high costs and lack of federal regulation often make ART procedures inaccessible to lower-income populations, with significant variability in service quality and ethical standards across states. Despite generally lower costs, bureaucratic hurdles and strict eligibility criteria can limit access, creating disparities in reproductive opportunities for various groups.15

GENERAL CHALLENGES IN REGULATING ART CLINICS

1. Rapid Technological Advancements

Pace vs. Regulation: The swift progress in reproductive technologies—ranging from gene editing to novel embryo screening methods—often outpaces the development of regulatory frameworks, leading to potential gaps in oversight and unforeseen ethical dilemmas.16

2. Ethical Dilemmas and Moral Considerations

ART raises fundamental ethical questions about the extent to which human reproduction should be controlled or modified. Issues such as embryo selection, designer babies, and the potential for genetic enhancements challenge existing ethical and moral boundaries. The commercialization of reproductive services, particularly in surrogacy and gamete donation, poses risks of exploitation—especially in economically disadvantaged populations—necessitating robust safeguards.17

3. International Disparities and Cross-Border Reproductive Care

Different countries adopt divergent approaches to ART regulation, creating challenges when couples or individuals seek cross-border reproductive services. These inconsistencies can lead to legal uncertainties, ethical conflicts, and potential exploitation. Coordinating international guidelines and best practices is complex, given varying cultural, legal, and ethical perspectives on reproduction.18

4. Socioeconomic and Accessibility Issues

High costs and limited insurance coverage can make ART accessible only to wealthier segments of society, exacerbating inequalities in reproductive rights and opportunities. There is also the challenge of ensuring that regulations do not inadvertently discriminate against certain groups—such as single individuals, LGBTQ+ couples, or non-residents—thus raising questions about equal access and fairness.19

5. Privacy, Autonomy, and Data Protection

ART procedures involve sensitive personal and genetic information. Protecting patient privacy while enabling the necessary sharing of data for research and clinical improvement is a significant regulatory challenge. Ensuring that patients fully understand the implications of ART procedures—including potential risks, long-term consequences, and ethical issues—is essential yet challenging, especially as procedures become more complex.20

6. Enforcement and Compliance

Effective enforcement of ART regulations requires consistent monitoring and a clear set of standards. Variability in regulatory enforcement—whether due to resource constraints or differing interpretations of the law—can undermine the intended protections. As technologies and societal values evolve, regulatory frameworks must be adaptable and continuously reviewed to remain effective and relevant. Regulating ART presents a multifaceted challenge that intertwines legal, ethical, technological, and socioeconomic factors. The U.S. and Indian perspectives highlight contrasting approaches: the U.S. leans toward an individual-rights framework with decentralized oversight, while India emphasizes ethical regulation and state control. Beyond these national comparisons, broader challenges—such as keeping pace with rapid technological advances, addressing ethical dilemmas, ensuring equitable access, and harmonizing international standards—remain central to developing a regulatory framework that both protects and empowers individuals. Moving forward, creating adaptive, balanced policies will be crucial in addressing these challenges while upholding fundamental reproductive rights.21

SUGGESTIONS

1.  Institutionalizing Responsibility in ART Clinics: Much like the institutional governance discussed in healthcare settings, ART clinics should create a structure that clearly defines authority and responsibility. This includes understanding the clinic as a 'total institution,' where surrogates, intended parents, and medical staff follow well-defined roles, ensuring consistent discipline and adherence to protocols. Clear authority structures help cement a system of accountability, where information is used to guide and discipline practices, thereby promoting transparency and efficiency in the surrogacy process.

2.  Medical Surveillance and Adherence: Similar to the 'ritual of adherence' in healthcare settings, ART clinics must institute strong protocols for monitoring surrogates throughout the pregnancy. Policing practices like regular check-ups, tests, and adherence to medical guidelines should be emphasized, ensuring the surrogate's health and the safety of the baby. The clinic should use information to maintain discipline and provide surveillance without crossing boundaries into invasive control, ensuring a balance of trust and oversight.

3.  The Language of Responsibility and Professionalism: In ART clinics, professionalism, care, and morality must shape the discourse around surrogacy. Medical professionals must be equipped to communicate effectively with surrogates and intended parents, offering tailored advice while maintaining empathy. Beyond mere adherence to medical protocols, personal involvement, and moral convictions should be considered to ensure that surrogates feel respected and valued, not merely as carriers but as active participants in the process.

4.  Addressing Patient Agency and Autonomy: Just as healthcare settings recognize the need for patient agency, ART clinics should ensure surrogates are not just passive recipients of care but active agents in managing their health. This includes recognizing their ability to make informed decisions and ensuring they have access to the resources and information they need to make these decisions. The agency of the surrogate should be central to the clinic's operations, ensuring that their autonomy is respected throughout the surrogacy process.

5.  Personal Involvement in Ethical Practice: ART clinics must go beyond professional duty and incorporate moral responsibility into their practices. Medical professionals should be personally involved in the care process, ensuring that the surrogacy arrangement is ethical and that surrogates are treated with dignity. This responsibility extends to considering the moral implications of offering ART services, including the ethical issues surrounding access to free ART or the financial responsibilities of intended parents.

CONCLUSION

Surrogacy within ART clinics is a complex process that requires clear institutional frameworks, ethical professionalism, and a commitment to patient agency. By institutionalizing responsibility and creating a strong governance system, ART clinics can ensure that surrogates, intended parents, and medical staff work together within a structured, accountable, and transparent environment. Adopting practices of medical surveillance while respecting the autonomy of surrogates and communicating with empathy fosters an ethical atmosphere. Personal involvement from medical professionals, paired with a moral approach to surrogacy, ensures that all parties involved are treated with respect and fairness. By refining these elements, ART clinics can create a more inclusive, ethically sound, and successful surrogacy process that respects both the rights of the surrogate and the intended parents.

*****

Footnotes

2. Shruti Das & Deepshikha Routray, The Ethical Quandaries of Commercialized Surrogacy in India and Its Representation in Bollywood Films, 27 J. Int'l Women's Stud. 6 (2025).

3. Jim Buchanan, Baby M & Surrogate Motherhood: A Resource Guide, Vance Biblios, 1987.

4. Id.

5. Illegal Oocyte Sale: 4 Private Hospitals in Tamil Nadu to Face Action for Violations, The Hindu (July 14, 2022), https://www.thehindu.com/news/national/tamil-nadu/illegal-oocyte-sale-4-private-hospitals-in-tamil-nadu-toface-action-for-violations/article65638562.ece.

6. R.S. Sharma et al., Infertility & Assisted Reproduction: A Historical & Modern Scientific Perspective, 148 Indian J. Med. Res. 13 (2018).

7. Prabha Kotiswaran, Surrogacy Regulation Is Stuck Between Market, Family and State, The Wire (Mar. 28, 2018), https://thewire.in/women/stuck-between-market-family-and-state-empower-surrogates-themselves.

8. Using the Theory of Planned Behaviour to Study Fertility Intentions in Romania, Procedia Econ. & Fin., 17 Procedia Econ. & Fin. 123 (2014).

9. The Landscape of Assisted Reproductive Technology Access in India, 5 Reproduction & Fertility e0079 (2024), https://doi.org/10.1530/RAF-24-0079.

10. Penalization of Assisted Reproductive Techniques (ART) Centres for Medical Negligence, SS Rana & Co. (2024), https://ssrana.in/articles/penalization-of-assisted-reproductive-techniques-art-centres-for-medical-negligence/.

11. Radhika Yadav & Pavan Kasturi, A Comprehensive Analysis on Reproductive Health and Surrogacy in India: A Study on the Law, Policy, and Practice, SCC Online (Aug. 10, 2022, 3:44 PM), https://www.scconline.com/blog/post/2021/09/27/reproductive-health-and-surrogacy-in-india/.

12. Surrogacy Pros & Cons: What You Should Know, Thompson Dove Law Grp. LLC (July 31, 2022, 5:24 PM), https://tdlawgroup.com/home/surrogacy-and-assisted-reproduction/surrogacy-information/surrogacy-pros-cons/.

13. The Ethics of Surrogacy, Univ. of Birmingham (2018), https://www.birmingham.ac.uk/news-archive/2018/the-ethics-of-surrogacy-1.

14. Id.

15. R.S. Sharma, Social, Ethical, Medical & Legal Aspects of Surrogacy: An Indian Scenario, 140(Suppl. 1) Indian J. Med. Res. S13, S13–S16 (Nov. 2014).

16. Sarojini N.B., Astha, Preeti, Anjali & Deepa, Commercialisation of Surrogacy in the Indian Context, Medico Friends Circle Bull., Aug.-Sep. 2008, at 5-7.

17. Ethical Guidelines for the Use of Assisted Reproductive Technology, Australian Gov't, Dep't of Health & Aged Care, https://www.surrogacy.gov.au/surrogacy-in-australia/ethical-guidelines-use-assisted-reproductive-technology.

18. Id.

19. Anirudh Malpani, Are We Exploiting the Infertile Couple?, 8(1) Issues Med. Ethics (Jan.–Mar. 2000), http://www.issuesinmedicalethics.org/081or024.html (last visited Dec. 30, 2008).

20. A. Ghai & R. Johri, Prenatal Diagnosis: Where Do We Draw the Line?, 15(2) Indian J. Gender Stud. 291, 291–316 (May-Aug. 2008).

21. Id.

How to cite

Varalika S. Parashar, Roles and Responsibilities of Art Clinics in India: A Comparative Analysis, 8 Int'l J.L. Mgmt. & Human. 1783 (2025).

Cite this article

Varalika S. Parashar, Roles and Responsibilities of Art Clinics in India: A Comparative Analysis, 8 Int'l J.L. Mgmt. & Human. 1783 (2025).
Chat with us